Ophthalytics’ AI Retina Screening System Makes a Splash at ARVO 2023
Ophthalytics stole the spotlight at ARVO 2022, the world’s largest ophthalmology conference, with groundbreaking Artificial Intelligence (AI) models. These highly accurate and adaptable solutions impressed attendees from around the globe, earning recognition for their compatibility with diverse cameras and fundus images. With a steadfast commitment to ending preventable blindness caused by Diabetic Retinopathy and a robust pipeline addressing glaucoma, AMD, ROP, and cardiovascular risks. Ophthalytics also offers data science and deep learning advisory services, providing comprehensive support to the field.
| We’re on a Mission
to Advance Healthcare
Our mission is rooted in harnessing deep-learning AI to advance health equity by providing life-changing care to underserved communities. Although we are starting with diabetic retinopathy – and Nsight360 – we are already working on AI applications that will provide early diagnosis for a host of other diseases.
| We’re on a Mission
to Advance Healthcare
Our mission is rooted in harnessing deep-learning AI to advance health equity by providing life-changing care to underserved communities. Although we are starting with diabetic retinopathy – and Nsight360 – we are already working on AI applications that will provide early diagnosis for a host of other diseases.
